Research Calls I
-
Upgrades:
- Atea Pharmaceuticals (AVIR) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $6.88
- Dell (DELL) upgraded to Equal Weight from Underweight at Barclays; tgt $97
- Ducommun (DCO) upgraded to Buy from Neutral at Goldman; tgt raised to $80
- First Industrial Realty (FR) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $64
-
Downgrades:
- Academy Sports + Outdoors (ASO) downgraded to Hold from Buy at TD Cowen; tgt lowered to $54
- CenterPoint (CNP) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $28
- Cytokinetics (CYTK) downgraded to Neutral from Buy at Goldman; tgt lowered to $60
- Danimer Scientific (DNMR) downgraded to Hold from Buy at TD Cowen; tgt lowered to $1
-
Others:
- Artiva Biotherapeutics (ARTV) initiated with a Buy at Needham; tgt $23
- Artiva Biotherapeutics (ARTV) initiated with an Outperform at Wedbush; tgt $18
- Artiva Biotherapeutics (ARTV) initiated with a Buy at TD Cowen
- Artiva Biotherapeutics (ARTV) initiated with an Overweight at Cantor Fitzgerald; tgt $23
- Artiva Biotherapeutics (ARTV) initiated with a Buy at Jefferies; tgt $21
- Cintas (CTAS) initiated with an Underweight at Wells Fargo; tgt $735
- Ecolab (ECL) initiated with an Overweight at Wells Fargo; tgt $270
- Equifax (EFX) initiated with an Overweight at Wells Fargo; tgt $340
- FactSet (FDS) initiated with an Equal Weight at Wells Fargo; tgt $435
- Fair Isaac (FICO) initiated with an Overweight at Wells Fargo; tgt $2100
- Hormel Foods (HRL) upgraded to Buy from Neutral at Citigroup; tgt raised to $37
- Inozyme Pharma (INZY) resumed with a Buy at Jefferies; tgt raised to $17